CDC Advises RSV Shots for Seniors 60+
TL;DR Summary
A federal advisory panel in the US has recommended two vaccines developed by Pfizer and GSK to combat respiratory syncytial virus (RSV) for all Americans aged 65 and over, and for adults aged 60 and over based on individual needs and a doctor’s consultation. RSV is the leading cause of hospitalisations among newborns and younger children, and causes more than 177,000 hospitalisations and 14,000 deaths among older adults each year. The vaccines are expected to become available by fall.
- RSV vaccine: CDC panel recommends shots for American adults 65 and up USA TODAY
- CDC: Adults 65+ should get this vaccine WJW FOX 8 News Cleveland
- RSV shots from Pfizer, GSK recommended for people 60 and older FiercePharma
- CDC advisers vote to recommend first RSV vaccines for seniors CBS News
- Next Vaccine You Should Get? U.S. Health Advisers Back RSV Shots The Wall Street Journal
Reading Insights
Total Reads
0
Unique Readers
9
Time Saved
1 min
vs 2 min read
Condensed
77%
343 → 79 words
Want the full story? Read the original article
Read on USA TODAY